Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia

Trial Profile

Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia

Completed
Phase of Trial: Phase II/III

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms RIMINI-Pilot
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 23 May 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-000030-35).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top